top of page


News
Categories
Sign up
Featured Posts


Archive


- Nov 26, 2019
Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
bottom of page